SDIC Fund Management
China's Canton Biologics raises $41m Series C
Chinese pharmaceutical industry services provider Canton Biologics has completed a CNY 300m (USD 41m) Series C round led by state-owned SDIC Venture Capital.
China's Neurophth Biotechnology gets $97m Series C extension
Neurophth Biotechnology, a China-based gene therapy developer specialising in ocular diseases, has raised nearly CNY 700m (USD 97m) in an extended Series C round.
Deal focus: National team drives Hithium towards China IPO
Government and state-owned investors accounted for most, but not all, of Xiamen Hithium Energy Storage Technology’s USD 622m Series C, underlining where China’s strategic priorities lie
SDIC leads $97m Series A for China's Pyrotech Therapeutics
China-based Pyrotech Therapeutics, which develops treatments for inflammation and tumours, has raised a Series A of CNY 700m (USD 97m) led by state-owned investor SDIC Venture Capital.
China's Hithium Energy Storage raises $622m
Xiamen Hithium Energy Storage Technology, a China-based battery manufacturer, has raised a Series C round of CNY 4.5bn (USD 622m) led by Beijing Financial Street Capital and China Life Insurance's private equity unit.
China's Yuze Semiconductor raises $178m
China’s Yuze Semiconductor, a specialist in single-crystal high-efficiency silicon wafers, has raised a CNY 1.2bn (USD 178m) Series B round featuring Goldstone Investment, a PE unit of CITIC Securities.
China semiconductor player Eswin Material raises $576m
Eswin Material, the integrated circuit manufacturing unit of Eswin Technology Group, has raised CNY 4bn（USD 576m）in Series C funding led by the New Materials Fund of China National Building Material.
China CRO Safe Pharma gets $71m Series D
Safe Pharmaceutical Research Institute, a Beijing-based clinic research organization (CRO) focused on novel drugs, has raised a CNY500m (USD 71m) Series D round led by SDIC Venture Capital and China State-owned Venture Capital Fund.
China battery maker WeLion secures $207m Series D
Beijing WeLion New Energy Technology, a China-based manufacturer of lithium-ion batteries, has raised CNY 1.5bn (USD 207m) in Series D funding led by Chengtong State-Owned Enterprises Mixed Ownership Reform Fund.
China circuit board maker JLC raises $129m
Chinese circuit board manufacturing company Jialichuang (JLC) has raised CNY 900m (USD 129m) from State Development & Investment Corporation (SDIC), Eastern Bell Capital and Jianfa Xinxing Investment.
China stem cell drug developer Baylx raises $47m
Baylx, a Beijing-based drug developer that utilises stem cell technology, has raised CNY 300m （USD 47m）across two rounds - a Series B and a Series B extension.
China cancer drug developer InxMed raises $50m
InxMed, a China-based biotech company focused on oncology treatments, has raised a USD 50m Series B round led by SDIC China Merchants Investment.
Deal focus: Freight player G7 eyes public listing
Having expanded its business scope from hardware into software and financial services, G7 Network is positioning its recent USD 200m PE investment as a pre-IPO round
China truck smart devices manufacturer raises $200m
G7 Networks, a Chinese company that uses smart devices to track cargo trucks, has raised a USD 200m round led by Trustbridge Partners, and State Development & Investment Corporation (SDIC). Several existing investors re-upped.
China ocular drugs developer raises $63m
China’s Neurophth Biotechnology, a gene therapy developer for ocular diseases, has raised a RMB400 million ($63 million) Series C round led by SDIC China Merchants Investment and Sequoia Capital China.
China EV battery maker raises $1.5b
Svolt Energy Technology, formerly the battery manufacturing unit of Chinese automaker Great Wall Motor, has raised RMB10.28 billion ($1.5 billion) in a Series B funding round led by Bank of China Investment.
Hong Kong sees rush of VC-backed biotech IPO filings
Five VC-backed pre-revenue Chinese biotech companies have filed to list in Hong Kong over the past two weeks, doubling the size of the IPO pipeline in this category.
China drug developer Adlai Nortye gets $100m Series D
Adlai Nortye, a Chinese biopharma player specializing in cancer treatments, has raised $100 million in Series D funding.
China mRNA vaccine provider Abogen raises $92m
Suzhou Abogen Biosciences, a Chinese mRNA vaccine provider, has raised RMB600 million ($92 million) led by PICC Capital - an investment unit under People’s Insurance Company of China - and state-backed SDIC Venture Capital.
China EV battery maker raises $542m Series A
Svolt Energy Technology, formerly the battery business unit of Chinese automaker Great Wall Motor, has raised a RMB3.5 billion ($542 million) Series A round featuring a string of government-linked investors.
CPE, SDIC lead $46m round for China's Jaka Robotics
Chinese industrial robot manufacturer Jaka Robotics has raised RMB300m ($46m) in Series C funding led by CPE and State Development and Investment Corporation (SDIC).
China's LianBio receives $310m round
LianBio, a Chinese biotech start-up incubated earlier this year by life sciences investor Perceptive Advisors, has raised $310 million from a group featuring BlackRock.
China EV maker WM Motor raises $1.5b
Chinese electric vehicle (EV) manufacturer WM Motor has raised RMB10 billion ($1.47 billion) in funding led by SAIC Motor and several government investment platforms. It said to be the largest single round in China's EV industry.
CDH, SDIC lead $62m Series C for Virogin Biotech
Virogin Biotech, a drug developer based in China and Canada, has received $62 million in Series C funding led by CDH Invesmtents and a subsidiary of State Development and Investment Corporation (SDIC).